(redirected from phenazine)
Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.


a phenothiazine compound used orally and intramuscularly as an antipsychotic agent and antiemetic.


Apo-Perphenazine (CA), Fentazin (UK)

Pharmacologic class: Phenothiazine, dopaminergic antagonist

Therapeutic class: Antipsychotic, antiemetic

Pregnancy risk category NR


Unknown. Thought to antagonize dopamine and serotonin type 2 in CNS. Also antagonizes muscarinic receptors in respiratory tract, causing cholinergic activation.


Tablets: 2 mg, 4 mg, 8 mg, 16 mg

Indications and dosages

Schizophrenia in nonhospitalized patients

Adults and children older than age 12: Initially, 4 to 8 mg P.O. t.i.d.

Schizophrenia in hospitalized patients

Adults and children older than age 12: Initially, 8 to 16 mg P.O. two to four times daily, increased p.r.n.; avoid dosages greater than 64 mg daily.

Severe nausea and vomiting

Adults: 8 to 16 mg P.O. daily in divided doses, to a maximum of 24 mg.

Off-label uses

• Intractable hiccups


• Hypersensitivity to drug, its components, or related compounds

• Blood dyscrasias

• Bone marrow depression

• Hepatic damage

• Subcortical damage

• Coma

• Concurrent use of high-dose CNS depressants


Use cautiously in:

• respiratory disorders, hepatic or renal dysfunction, breast cancer, alcohol withdrawal symptoms, suicidal tendency, surgery

• patients taking CNS depressants or anticholinergics

• elderly patients

• pregnant or breastfeeding patients

• children younger than age 12.


• Give with food to avoid GI upset.

Adverse reactions

CNS: drowsiness, dizziness, insomnia, vertigo, headache, hyperactivity, nocturnal confusion, bizarre dreams, tremor, ataxia, slurring, exacerbation of psychotic symptoms, paranoid reactions, parkin-sonism, dystonias, akathisia, tardive dyskinesia, hyperreflexia, cerebrospinal fluid abnormality, catatonic-like state, paradoxical stimulation, seizures, neuroleptic malignant syndrome

CV: hypotension, orthostatic hypotension, hypertension, peripheral edema, ECG changes, tachycardia, bradycardia, cardiac arrest, heart failure

EENT: glaucoma, blurred vision, miosis, mydriasis, corneal and lens deposits, pigmentary retinopathy, oculogyric crisis, photophobia, nasal congestion, dysphagia

GI: nausea, vomiting, diarrhea, constipation, obstipation, abnormal tongue color or movement, dry mouth, anorexia, adynamic ileus

GU: dark urine, urinary retention, urinary frequency, urinary incontinence, bladder paralysis, galactorrhea, lactation, breast enlargement, menstrual irregularities, inhibited ejaculation, libido changes

Hematologic: hemolytic anemia, leukopenia, agranulocytosis, thrombocytopenic purpura

Hepatic: jaundice, biliary stasis

Metabolic: hyponatremia, glycosuria, hyperglycemia, hypoglycemia, syndrome of inappropriate antidiuretic hormone secretion, pituitary tumor

Musculoskeletal: numbness and aching of arms and legs

Respiratory: dyspnea, suppressed cough reflex, asthma, bronchospasm, laryngospasm, laryngeal edema

Skin: urticaria, pallor, erythema, eczema, pruritus, perspiration, pigmentation changes, photosensitivity, angioedema, exfoliative dermatitis

Other: increased appetite, weight gain, fever, systemic lupus erythematosuslike syndrome, hypersensitivity reactions including anaphylactoid reaction


Drug-drug. Anticholinergics: increased risk of adverse anticholinergic reactions

CNS depressants: increased perphenazine effects, increased adverse CNS reactions

Tricyclic antidepressants: increased perphenazine blood level, greater risk of adverse reactions

Drug-diagnostic tests. Eosinophils, liver function tests: increased values Glucose: increased or decreased level Granulocytes, hemoglobin, platelets, sodium, white blood cells: decreased levels

Pregnancy test: false-positive result

Drug-herbs. Kava: dystonic reactions

St. John's wort: photosensitivity

Yohimbe: yohimbe toxicity

Drug-behaviors. Alcohol use: increased CNS depression

Sun exposure: increased risk of photosensitivity reaction

Patient monitoring

Watch for anaphylactoid reaction and angioedema. Monitor neurologic status; stay alert for signs and symptoms of neuroleptic malignant syndrome (high fever, unstable blood pressure, stupor, muscle rigidity, autonomic dysfunction), parkinsonian symptoms, and catatonic-like state.

• Monitor cardiovascular status and vital signs periodically.

Evaluate respiratory status, especially for dyspnea and airway spasm.

Monitor CBC, glucose level, and liver function tests. Watch for evidence of blood dyscrasias.

Patient teaching

• Explain importance of combining drug therapy with psychotherapy.

• Tell patient to take exactly as prescribed and to report adverse reactions promptly.

• Instruct patient to avoid sun exposure and to wear sunscreen outdoors to prevent photosensitivity reaction.

• Advise patient to consult prescriber before taking other prescription drugs or over-the-counter preparations.

• Caution patient to avoid driving and other hazardous activities until he knows how drug affects him.

• Instruct patient to avoid alcohol, smoking, caffeine, and herbs.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, herbs, and behaviors mentioned above.


An antipsychotic of the phenothiazine type.


A crystalline compound, C21H26ClN3OS, used as a tranquilizer especially in the treatment of psychosis and to prevent or alleviate nausea and vomiting.


Etrafon, Trilafon® Pharmacology A phenothiazine and tricyclic antidepressant combination used to manage anxiety, depression, agitation, severe N&V, hiccups, pain Adverse effects Extrapyramidal symptoms–involuntary movement–opisthotonus, trismus, torticollis, retrocollis, aching, numbness of limbs, motor restlessness, oculogyric crisis, hyperreflexia, dystonia, sedative effects, jaundice, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenic purpura, pancytopenia. See Mitriptyline.


A phenothiazine derivative drug used in the treatment of SCHIZOPHRENIA and other psychotic conditions. It is also used to relieve severe vomiting and control persistent hiccups. A brand name is Fentazin.
References in periodicals archive ?
Bacterial strains generates increase resistance towards antibiotics, germicides and disinfectants in this regards phenazines have been of great importance from last decades to pharmaceutical and clinical researchers in treating the antibiotic-resistant and susceptible infections (Shouny et al., 2011).
To measure the parameters of swelling and diffusion, PHA hydrogels was accurately weighed, and transferred into aqueous phenazine dyes solutions of 20 mg [L.sup.-1] in a beaker.
Skarina et al., "Structure and function of the phenazine biosynthetic protein PhzF from Pseudomonas fluorescens," Proceedings of the National Academy of Sciences of the United States of America, vol.
Phenazine, PCA and PYO were identified as first time from oil palm rhizospheric UPMP3 strain of P.
Superoxide radicals were generated in 3.0 ml of Tris-HCL buffer (16 mM pH 8.0) which contained 78 M AY-nicotinamide adenine dinucleotide (reduced form NADH) 50 M nitroblue tetrazolium (NBT) 10 M phenazine methosulfate (PMS) and 50 L of plasma sample.
The wells were then washed, filled with 100 [micro]L of D-10, 20 [micro]L of the Promega[TM] solution MTS/PMS (phenazine methosulfate) and incubated for 2 h.
The most studied bioactive metabolites of marine algae include brominated phenols, carotenoids, heterocyclics, nitrogen heterocyclics, kainic acids, guanidine derivatives, phenazine derivatives, amino acids and amines, sterols, sulfated polysaccharides and prostaglandins.
100l of serum sample 1.2ml of sodium phosphate buffer (pH 8.3 0.052M) 100l of phenazine methosulphate (186m) 300 l of nitro blue tetrazolium (300m) 200 l of NADH (750m) and 4.0 ml of nbutanol were used and absorbance was recorded at 560nm.Estimation of CAT activity: Catalase activity was measured by the method of Aebi.15 The supernatant was used for the estimation of catalase.
After electrophoresis, the gels were sliced and then covered with a 0.75% agar solution at 45 [degrees]C made in 0.1 M tris buffer pH=8 containing glucose 10 mM, magnesium chloride 20 mM., adenosine diphosphate (ADP) 1 mM, nicotinammide adenine dinucleotide phosphate (NADP) 0.4 mM, phenazine methosulphate (PMS) 0.012%, tetrazolium salt (MTT) 0.012%, glucose-6-phosphate dehydrogenase (G6PD) 0.04 units/ml and hexokinase 0.08 units/ml.
Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity.
After washing, we incubated the cells with fresh medium for 72 h, followed by staining with the Cell Titer 96 Aqueous One Solution Reagent (Promega), which contains a novel tetrazolium compound (3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-[4-sulfophenyl]-2H-tetrazolium, inner salt; MTS) and an electron-coupling reagent (phenazine ethosulfate).
They found that the bacterial colonies produced a phenazine gradient that is likely to be of physiological significance.